Clinical Trial Update: Long Term Study to Evaluate Safety and Efficacy of M518101 in Subjects With Plaque Psoriasis [Phase 3]

View source ↗

Summary

Phase 3 long-term study evaluating the safety and efficacy of M518101 in subjects with plaque psoriasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• M518101

Snippet

Sponsor: Maruho North America Inc. | Conditions: Psoriasis | Phase 3 | Status: COMPLETED